Alberta Investment Management Corp Buys 58,826 Shares of Avanos Medical, Inc. (NYSE:AVNS)

Alberta Investment Management Corp lifted its stake in Avanos Medical, Inc. (NYSE:AVNSFree Report) by 16.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 413,418 shares of the company’s stock after acquiring an additional 58,826 shares during the quarter. Alberta Investment Management Corp’s holdings in Avanos Medical were worth $9,273,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Illinois Municipal Retirement Fund purchased a new position in shares of Avanos Medical in the third quarter worth approximately $563,000. Barclays PLC boosted its holdings in shares of Avanos Medical by 24.4% in the third quarter. Barclays PLC now owns 39,042 shares of the company’s stock worth $790,000 after buying an additional 7,646 shares during the last quarter. New York State Common Retirement Fund boosted its holdings in shares of Avanos Medical by 36.3% in the third quarter. New York State Common Retirement Fund now owns 38,470 shares of the company’s stock worth $778,000 after buying an additional 10,242 shares during the last quarter. Quantbot Technologies LP purchased a new position in shares of Avanos Medical in the third quarter worth approximately $237,000. Finally, Swiss National Bank boosted its holdings in shares of Avanos Medical by 1.1% in the third quarter. Swiss National Bank now owns 102,500 shares of the company’s stock worth $2,073,000 after buying an additional 1,100 shares during the last quarter. 95.17% of the stock is currently owned by institutional investors.

Avanos Medical Stock Up 0.3 %

Shares of AVNS stock traded up $0.05 during trading hours on Friday, reaching $19.91. 135,308 shares of the company’s stock were exchanged, compared to its average volume of 158,881. Avanos Medical, Inc. has a fifty-two week low of $17.24 and a fifty-two week high of $26.56. The stock’s 50 day moving average is $19.45 and its 200-day moving average is $19.94. The company has a current ratio of 2.28, a quick ratio of 1.47 and a debt-to-equity ratio of 0.14. The company has a market cap of $913.87 million, a price-to-earnings ratio of -14.97 and a beta of 0.97.

Avanos Medical (NYSE:AVNSGet Free Report) last announced its earnings results on Thursday, May 2nd. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.02). The business had revenue of $166.10 million for the quarter, compared to analyst estimates of $162.90 million. Avanos Medical had a negative net margin of 9.15% and a positive return on equity of 4.10%. The company’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the prior year, the company earned $0.27 earnings per share. Analysts predict that Avanos Medical, Inc. will post 1.38 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Michael Greiner sold 8,000 shares of Avanos Medical stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $19.12, for a total transaction of $152,960.00. Following the completion of the sale, the chief financial officer now owns 151,495 shares of the company’s stock, valued at $2,896,584.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.90% of the company’s stock.

Analyst Ratings Changes

AVNS has been the topic of several analyst reports. JMP Securities reaffirmed a “market perform” rating on shares of Avanos Medical in a report on Tuesday, May 7th. StockNews.com raised Avanos Medical from a “hold” rating to a “buy” rating in a research report on Saturday, May 11th.

Check Out Our Latest Analysis on AVNS

About Avanos Medical

(Free Report)

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.

Featured Articles

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical, Inc. (NYSE:AVNSFree Report).

Institutional Ownership by Quarter for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.